Hasil Pencarian  ::  Simpan CSV :: Kembali

"[Malaria masih menjadi beban kesehatan bagi Indonesia, terlebih lagi dengan perkembangan resistensi parasit terhadap pengobatan saat ini. Untuk itu, diperlukan penemuan terapi baru dengan segera. Pasak Bumi (Eurycoma longifolia) adalah tanaman asli Kalimantan yang terbukti secara in vitro dan in vivo memiliki aktivitas antiplasmodium. Penelitian ini ingin menguji efektivitas kombinasi ekstrak akar Pasak Bumi dosis 10 mg/kgBB (PB10) dan 20 mg/kgBB (PB20) dengan Artemisinin-based Combination Therapy (ACT) dosis 1,7 mg/kgBB pada mencit Swiss yang terinfeksi Plasmodium berghei. Pemberian obat dilakukan secara subkutan untuk meningkatkan bioavailabilitasnya, sehingga didapatkan hasil yang maksimal. Dengan menggunakan metode 4-day suppressive test, didapatkan pertumbuhan densitas parasitemia dan persentase inhibisi pertumbuhan secara berturut-turut: kontrol positif 22,08% dan 50,92%, PB10+ACT 5,22% dan 88,4%, PB20+ACT 3,5% dan 92,22%. Pemberian kombinasi meningkatkan efektivitas secara signifikan terhadap PB tunggal, tetapi tidak signifikan terhadap ACT tunggal. Meskipun demikian, peningkatan tersebut mengindikasikan adanya efek sinergis dari kedua zat dan membutuhkan penelitian lebih lanjut. Dari semua perlakuan, PB20+ACT memiliki efek antimalaria yang paling baik.;Malaria is still considered as a burden disease for Indonesia, especially with the fast developing resistance of parasite against current medication. Hence, the invention of novel therapy is needed immediately. Pasak Bumi (Eurycoma longifolia), a native plant in Kalimantan, has been proven to have in vivo and in vitro antiplasmodial activity. This study aims to test the effect of combination of E.longifolia and Artemisinin-based Combination Therapy (ACT) both given subcutaneously on parasitemia in mice infected with Plasmodium berghei. The doses of the extract tested in this experimental study were 10 (PB10) and 20 mg/kg BW (PB20). Using the 4-day suppressive test, the growth of parasite and growth inhibition percetage of each groups are as following: positive control 22,08% and 50,92%, PB10+ACT 5,22% and 88,4%, PB20+ACT 3,5% and 92,22%. The combination therapy showed significant increase in effectiveness compared to PB monotherapy but insignificant increase compared to ACT monotherapy. Despite the insignificance, this indicates synergistic effect of the two substances that needs further investigation. Among all groups, PB20+ACT showed the best antimalarial activity, Malaria is still considered as a burden disease for Indonesia, especially with the fast developing resistance of parasite against current medication. Hence, the invention of novel therapy is needed immediately. Pasak Bumi (Eurycoma longifolia), a native plant in Kalimantan, has been proven to have in vivo and in vitro antiplasmodial activity. This study aims to test the effect of combination of E.longifolia and Artemisinin-based Combination Therapy (ACT) both given subcutaneously on parasitemia in mice infected with Plasmodium berghei. The doses of the extract tested in this experimental study were 10 (PB10) and 20 mg/kg BW (PB20). Using the 4-day suppressive test, the growth of parasite and growth inhibition percetage of each groups are as following: positive control 22,08% and 50,92%, PB10+ACT 5,22% and 88,4%, PB20+ACT 3,5% and 92,22%. The combination therapy showed significant increase in effectiveness compared to PB monotherapy but insignificant increase compared to ACT monotherapy. Despite the insignificance, this indicates synergistic effect of the two substances that needs further investigation. Among all groups, PB20+ACT showed the best antimalarial activity]"

"[Malaria masih menjadi beban kesehatan bagi Indonesia, terlebih lagi dengan perkembangan resistensi parasit terhadap pengobatan saat ini. Untuk itu, diperlukan penemuan terapi baru dengan segera. Pasak Bumi (Eurycoma longifolia) adalah tanaman asli Kalimantan yang terbukti secara in vitro dan in vivo memiliki aktivitas antiplasmodium. Penelitian ini ingin menguji efektivitas kombinasi ekstrak akar Pasak Bumi dosis 10 mg/kgBB (PB10) dan 20 mg/kgBB (PB20) dengan Artemisinin-based Combination Therapy (ACT) dosis 1,7 mg/kgBB pada mencit Swiss yang terinfeksi Plasmodium berghei. Pemberian obat dilakukan secara subkutan untuk meningkatkan bioavailabilitasnya, sehingga didapatkan hasil yang maksimal. Dengan menggunakan metode 4-day suppressive test, didapatkan pertumbuhan densitas parasitemia dan persentase inhibisi pertumbuhan secara berturut-turut: kontrol positif 22,08% dan 50,92%, PB10+ACT 5,22% dan 88,4%, PB20+ACT 3,5% dan 92,22%. Pemberian kombinasi meningkatkan efektivitas secara signifikan terhadap PB tunggal, tetapi tidak signifikan terhadap ACT tunggal. Meskipun demikian, peningkatan tersebut mengindikasikan adanya efek sinergis dari kedua zat dan membutuhkan penelitian lebih lanjut. Dari semua perlakuan, PB20+ACT memiliki efek antimalaria yang paling baik.;Malaria is still considered as a burden disease for Indonesia, especially with the fast developing resistance of parasite against current medication. Hence, the invention of novel therapy is needed immediately. Pasak Bumi (Eurycoma longifolia), a native plant in Kalimantan, has been proven to have in vivo and in vitro antiplasmodial activity. This study aims to test the effect of combination of E.longifolia and Artemisinin-based Combination Therapy (ACT) both given subcutaneously on parasitemia in mice infected with Plasmodium berghei. The doses of the extract tested in this experimental study were 10 (PB10) and 20 mg/kg BW (PB20). Using the 4-day suppressive test, the growth of parasite and growth inhibition percetage of each groups are as following: positive control 22,08% and 50,92%, PB10+ACT 5,22% and 88,4%, PB20+ACT 3,5% and 92,22%. The combination therapy showed significant increase in effectiveness compared to PB monotherapy but insignificant increase compared to ACT monotherapy. Despite the insignificance, this indicates synergistic effect of the two substances that needs further investigation. Among all groups, PB20+ACT showed the best antimalarial activity, Malaria is still considered as a burden disease for Indonesia, especially with the fast developing resistance of parasite against current medication. Hence, the invention of novel therapy is needed immediately. Pasak Bumi (Eurycoma longifolia), a native plant in Kalimantan, has been proven to have in vivo and in vitro antiplasmodial activity. This study aims to test the effect of combination of E.longifolia and Artemisinin-based Combination Therapy (ACT) both given subcutaneously on parasitemia in mice infected with Plasmodium berghei. The doses of the extract tested in this experimental study were 10 (PB10) and 20 mg/kg BW (PB20). Using the 4-day suppressive test, the growth of parasite and growth inhibition percetage of each groups are as following: positive control 22,08% and 50,92%, PB10+ACT 5,22% and 88,4%, PB20+ACT 3,5% and 92,22%. The combination therapy showed significant increase in effectiveness compared to PB monotherapy but insignificant increase compared to ACT monotherapy. Despite the insignificance, this indicates synergistic effect of the two substances that needs further investigation. Among all groups, PB20+ACT showed the best antimalarial activity]"

"[Resistensi obat antimalaria mendorong pengembangan obat antimalaria baru. Salah satu alternatif pengembangan obat antimalaria adalah mengombinasikan klorokuin dengan komponen lain, contohnya ekstrak akar pasak bumi (Eurycoma longifolia jack.). Berbagai penelitian in vitro maupun in vivo telah membuktikan potensi pasak bumi sebagai antimalaria. Penelitian ini bertujuan untuk mengetahui efek pemberian kombinasi ekstrak akar pasak bumi dan klorokuin secara injeksi subkutan pada mencit (Mus musculus) yang diinfeksi Plasmodium berghei. Perlakuan yang diberikan adalah pemberian ekstrak akar pasak bumi dengan dosis 10 mg/kgBB, 20 mg/kgBB, serta kombinasi ekstrak akar pasak bumi dengan dua dosis tersebut dan klorokuin. Berdasarkan Peters 4-days suppressive test, pertumbuhan parasitemia mencit yang diberikan kombinasi obat memiliki nilai yang mendekati kontrol positif (0,60%), yaitu 0,60% pada dosis kombinasi pasak bumi 10 mg/kgBB dan 0,50% pada dosis 20 mg/kgBB namun analisis statistik menunjukkan perbedaan tersebut tidak bermakna (p>0,05). Hasil penghitungan penghambatan pertumbuhan parasit menunjukkan kecenderungan yang sama. Penghambatan pertumbuhan parasit kontrol positif menunjukkan angka 97,9% sementara pemberian kombinasi obat menunjukkan angka 97,7% (dosis pasak bumi10 mg/kgBB) dan 98,2% (dosis pasak bumi 20 mg/kgBB). Hal ini menunjukkan bahwa tidak ada perbedaan bermakna antara efek pemberian kombinasi ekstrak akar pasak bumi dan klorokuin secara injeksi subkutan dibandingkan dengan terapi klorokuin saja;Antimalarial drug resisstance demand us to develop new antimalarial drug. One of the alternative is combining chloroquine with new compund, for example pasak bumi root extract (Eurycoma longifolia jack). Many studies have shown the potency of pasak bumi root extract as a antimalarial drug. This study is aim to investigate the effect of combination of pasak bumi root extract and chloroquine which is administrated by subcoutaneous injection to Plasmodium berghei-infected mice. Mice were given pasak bumi root extract only with 10 mg/kgBW and 20 mg/kgBW dose , also combination therapy of pasak bumi root extract on same dose and choloquine. Based on Peters 4-days suppressive test, parasite growth in mice with combination therapy was nearing the postive control value (0.60%), 0.60% for 10 mg/kgBW dose and 0.50% for 20 mg/kgBW dose. However, the statistic analysis showed the difference was not significant (p>0.05). Growth inhibition counting showed the same trend. Positive control growth inhibiton value is 97.9% meanwhile the combination therapy group has 97.7% for 10 mg/kgBW dose and 98.2% for 20 mg/kgBW dose. The study suggests that there were no significat difference between the effect of subcutaneously administrated combination of pasak bumi extract root-chloroquine and chloroquine only therapy., Antimalarial drug resisstance demand us to develop new antimalarial drug. One of the alternative is combining chloroquine with new compund, for example pasak bumi root extract (Eurycoma longifolia jack). Many studies have shown the potency of pasak bumi root extract as a antimalarial drug. This study is aim to investigate the effect of combination of pasak bumi root extract and chloroquine which is administrated by subcoutaneous injection to Plasmodium berghei-infected mice. Mice were given pasak bumi root extract only with 10 mg/kgBW and 20 mg/kgBW dose , also combination therapy of pasak bumi root extract on same dose and choloquine. Based on Peters 4-days suppressive test, parasite growth in mice with combination therapy was nearing the postive control value (0.60%), 0.60% for 10 mg/kgBW dose and 0.50% for 20 mg/kgBW dose. However, the statistic analysis showed the difference was not significant (p>0.05). Growth inhibition counting showed the same trend. Positive control growth inhibiton value is 97.9% meanwhile the combination therapy group has 97.7% for 10 mg/kgBW dose and 98.2% for 20 mg/kgBW dose. The study suggests that there were no significat difference between the effect of subcutaneously administrated combination of pasak bumi extract root-chloroquine and chloroquine only therapy.]"

"[Resistensi yang terjadi pada beberapa obat antimalaria, seperti klorokuin, mendasari gencarnya dilakukan penelitian yang bertujuan untuk menemukan terapi antimalaria alternatif, salah satunya dengan memanfaatkan potensi herbal dari alam Indonesia. Ekstrak tanaman yang terbukti pada penelitian in-vivo memiliki efek antimalaria adalah akar pasak bumi (Eurycoma longifolia jack). Penelitian ini merupakan penelitian eksperimental in-vivo yang menguji ekstrak akar pasak bumi dengan dosis 60 mg/kgbb, 75 mg/kgbb, dan 90 mg/kgbb terhadap mencit (Mus musculus) yang terinfeksi Plasmodium berghei. Peningkatan densitas parasitemia pada hari ke-4 terapi dosis 60 mg/kgbb lebih tinggi dari kontrol negatif, sedangkan terapi dosis 75 mg/kgbb dan 90 mg/kgbb lebih rendah dari kontrol negatif namun perbedaannya tidak signifikan secara statistik. Ditinjau dari persentase inhibisi parasitemia, terapi dosis 60 mg/kgbb memiliki persentase inhibisi parasitemia negatif, sedangkan terapi dosis 75 mg/kgbb dan 90 mg/kgbb memiliki persentase inhibisi parasitemia < 50%. Ditinjau dari kadar hemoglobin, ketiga dosis perlakuan memiliki kadar hemoglobin yang fluktuatif dan cenderung menurun hingga pada kondisi anemia. Hal ini menunjukkan bahwa ekstrak akar pasak bumi dosis 60 mg/kgbb tidak memiliki efek antimalaria, sedangkan dosis 75 mg/kgbb dan 90 mg/kgbb memiliki efek antimalaria namun kurang adekuat. Terapi dosis 90 mg/kgbb menunjukkan peningkatan densitas parasitemia hari ke-4 yang paling rendah dan persentase inhibisi parasitemia paling baik. Dengan demikian disimpulkan bahwa terapi ekstrak akar pasak bumi kurang tepat digunakan sebagai terapi tunggal malaria;Resistance on malaria medication, for example klorokuin, underlie the study that aim to find alternative malaria treatment by using herbal potention from the nature of Indonesia. Herbal extract that had been proven in vivo experimental study that has antimalarial effect is Pasak bumi root (Eurycoma longifolia jack). This study is in vivo experimental study that giving Pasak bumi root extract by dose 60 mg/kgbw, 75 mg/kgbw, and 90 mg/kgbw to mice (Mus musculus) infected by Plasmodium berghei. The increase of parasitemia density in the 4th day of treatment by dose 60 mg/kgbw is higher than negative control, while treatment by dose 75 mg/kgbw and 90 mg/kgbw are lower than negative control, but the difference is not significant in statistic analysis. Reviewed from parasitemia inhibition persentage, treatment by dose 60 mg/kgbw has negative parasitemia inhibition persentage, while treatment by dose 75 mg/kgbw and 90 mg/kgbw have parasitemia inhibition persentage <50%. Reviewed from hemoglobin level, those treatment by three doses have fluctuative hemoglobin level and tend to be decreasing till reaching anemia. It shows that pasak bumi root extract by dose 60 mg/kgbw does not have antimalarial effect, while 75 mg/kgbw and 90 mg/kgbw have inadequate antimalarial effect. Treatment by dose 90 mg/kgbw shows the lowest increase of 4th day parasitemia density and the best parasitemia inhibition persentage. Thus, it could be concluded that pasak bumi root extract is not good enough to be used as single treatment of malaria, Resistance on malaria medication, for example klorokuin, underlie the study that aim to find alternative malaria treatment by using herbal potention from the nature of Indonesia. Herbal extract that had been proven in vivo experimental study that has antimalarial effect is Pasak bumi root (Eurycoma longifolia jack). This study is in vivo experimental study that giving Pasak bumi root extract by dose 60 mg/kgbw, 75 mg/kgbw, and 90 mg/kgbw to mice (Mus musculus) infected by Plasmodium berghei. The increase of parasitemia density in the 4th day of treatment by dose 60 mg/kgbw is higher than negative control, while treatment by dose 75 mg/kgbw and 90 mg/kgbw are lower than negative control, but the difference is not significant in statistic analysis. Reviewed from parasitemia inhibition persentage, treatment by dose 60 mg/kgbw has negative parasitemia inhibition persentage, while treatment by dose 75 mg/kgbw and 90 mg/kgbw have parasitemia inhibition persentage <50%. Reviewed from hemoglobin level, those treatment by three doses have fluctuative hemoglobin level and tend to be decreasing till reaching anemia. It shows that pasak bumi root extract by dose 60 mg/kgbw does not have antimalarial effect, while 75 mg/kgbw and 90 mg/kgbw have inadequate antimalarial effect. Treatment by dose 90 mg/kgbw shows the lowest increase of 4th day parasitemia density and the best parasitemia inhibition persentage. Thus, it could be concluded that pasak bumi root extract is not good enough to be used as single treatment of malaria]"

"[Munculnya fenomena resistensi dari berbagai obat malaria yang telah digunakan untuk melawan penyakit malaria merupakan suatu ancaman bagi dunia kesehatan untuk mencari terobosan baru dalam melawan penyakit malaria. Salah satunya dengan strategi pengobatan secara kombinasi. ACT (Artemisinin Combination Therapy) obat standar sebagai antimalaria. Ekstrak tanaman Akar Pasak Bumi (Eurycoma longifolia) diketahui memiliki potensi antimalaria. Dalam penelitian ini bertujuan menguji kombinasi ekstrak Akar Pasak Bumi (PB) dan ACT. Dengan menguji 2 dosis terdiri dari PB 60mg/kgBB tambah ACT 1.7 mg/kgBB; PB 75 mg/kgBB tambah ACT 1.7 mg/kgBB. Desain penelitian ini menggunakan eksperimental in vivo pada mencit (Mus musculus) yang terinfeksi Plasmodium berghei. Berdasarkan hasil analisa peningkatan parasitemia hari ke-4 menggunakan SPSS menunjukkan hasil tidak bermakna (p>0.05) pada kedua kelompok uji ketika dibandingkan dengan kontrol positif (ACT). Hal ini ditunjang dengan presentase inhibisi kedua kelompok (68.4%;54.46%) lebih kecil daripada kontrol positif (70%). Dapat disimpulkan bahwa kedua dosis kombinasi tidak bersifat sebagai antimalaria. Kombinasi dosis ekstrak akar pasak bumi 60 mg/kgBB dan ACT 1.7 mg/kgBB merupakan kelompok yang memiliki presentase daya hambat yang paling baik berdasarkan presentase daya hambat pada hari ke-4.;The emergence of the phenomenon of resistance from the malaria drug that has been used to combat malaria is a threat to the health of the world to search for new breakthroughs in the fight against malaria. One way by using combination treatment strategies. ACT (Artemisinin Combination Therapy) is a standard drug as anti-malaria. The extract of Pasak Bumi root (Eurycoma longifolia) had been known to have anti-malaria potency. This study aimed to test a combination of the extract of Pasak bumi root and ACT. By testing two doses consisting of PB 60 mg/kgBB and ACT 1.7 mg/kgBB; PB 75 mg/kgBB and ACT 1.7 mg/kgBB. Design of this study using an experimental in vivo in a mice (Mus musculus) infected by Plasmodium berghei. Based on the analysis of the increase in parasitemia day 4 using SPSS shows the results are not significant in both groups combination compared with positive control (ACT). It is supported with a percentage of inhibition of the two groups (68.4%;54.46%) is smaller than the positive control(70%). It can be concluded that both of doses combination is not as anti-malaria. Doses combination of PB 60 mg/kgBB and ACT 1.7 mg/kgBB has the best percentage of inhibition parasitemia, The emergence of the phenomenon of resistance from the malaria drug that has been used to combat malaria is a threat to the health of the world to search for new breakthroughs in the fight against malaria. One way by using combination treatment strategies. ACT (Artemisinin Combination Therapy) is a standard drug as anti-malaria. The extract of Pasak Bumi root (Eurycoma longifolia) had been known to have anti-malaria potency. This study aimed to test a combination of the extract of Pasak bumi root and ACT. By testing two doses consisting of PB 60 mg/kgBB and ACT 1.7 mg/kgBB; PB 75 mg/kgBB and ACT 1.7 mg/kgBB. Design of this study using an experimental in vivo in a mice (Mus musculus) infected by Plasmodium berghei. Based on the analysis of the increase in parasitemia day 4 using SPSS shows the results are not significant in both groups combination compared with positive control (ACT). It is supported with a percentage of inhibition of the two groups (68.4%;54.46%) is smaller than the positive control(70%). It can be concluded that both of doses combination is not as anti-malaria. Doses combination of PB 60 mg/kgBB and ACT 1.7 mg/kgBB has the best percentage of inhibition parasitemia]"

"Infeksi malaria merupakan masalah kesehatan yang masih menjadi perhatian dunia karena meningkatnya resistensi terhadap obat standar malaria, yaitu ACT. Pada penelitian ini, ekstrak tumbuhan yang digunakan adalah pasak bumi dan propolis sebagai antimalaria. Tujuan dari penelitian ini adalah untuk mengetahui efek antimalaria pada kelompok tunggal propolis dan kelompok kombinasi propolis dengan ekstrak akar pasak bumi. Mencit yang digunakan sejumlah 35 ekor dan terbagi atas 6 kelompok. Kelompok perlakuan terdiri atas dua kelompok kontrol, kelompok propolis tunggal dengan dosis 90 mg/kgBB dan 180 mg/kgBB dan kelompok kombinasi propolis dosis sama seperti tunggal dengan pasak bumi dosis 60 mg/kgBB dan 75 mg/kgBB. Plasmodium berghei 2 diinjeksikan pada setiap mencit dan dibuat apusan darahnya selama 8 hari untuk dilihat tingkat parasitemianya. Hasil dari penelitian menunjukan bahwa tidak ada perbedaan yang bermakna antara kontrol positif dengan kedua kelompok kombinasi p=0,136 dan 0,289 . Akan tetapi pemberian kedua dosis kombinasi propolis dengan pasak bumi GI: 97,97 dan 97,83 jauh lebih baik dibandingkan penggunaan tunggal propolis. Kontrol positif GI: 98,63 memberikan hasil yang lebih baik dibandingkan dengan propolis tunggal GI: 23,88 dan 51,66 . Perlakuan kombinasi lebih baik dibandingkan dengan perlakuan tunggal dalam menghambat parasitemia.

---

Malaria infection is still being a global concern because of the increasing resistance to standard drug malaria, Artemisinin Combination Therapy. In this research, plant extract, pasak bumi and propolis, was using as antimalarial. This study was conducted to find out antimalarial effect of single propolis and combination of propolis with pasak bumi root extract. Using 30 mice, the treatment group divided to 6 groups, consisted of two control groups, two groups of Single propolis with doses of 90 mg kgBW and 180 mg kgBW and two Combination groups of propolis doses same as Single propolis group with pasak bumi dose 60 mg kgBW and 75 mg kgBW. Plasmodium berghei 2 was injected in each mouse and made blood smear for 8 days to be seen parasitemia level. The results of the study showed that there was no significant difference between positive control with the two Combination groups p 0.136 and 0.289 . However, the Combination group of propolis and pasak bumi GI 97.97 and 97.83 is much better than Single propolis group. Positive control GI 98.63 had a better outcomes than Single propolis group GI 23.88 and 51.66 . Combination group is better than Single propolis group in inhibiting parasitemia. "

"Latar belakang. Malaria masih menjadi masalah kesehatan. Malaria disebabkan oleh parasit genus Plasmodium. Respon imun ternyata mempunyai kontribusi terhadap infeksi malaria, antara lain sitokin proinflamasi dan antiinflamasi yang berperanan pada beratnya infeksi malaria. Pasak bumi (Eurycoma longifolia Jack) merupakan obat tradisional sebagai antimalaria, dan imunomodulator. Tujuan penelitian ini adalah untuk menganalisis pengaruh ekstrak metanol akar pasak bumi sebagai antimalaria yang berpengaruh pada kadar sitokin proinflamasi dan antiinflamasi pada mencit yang terinfeksi P. berghei Metode. 5 mencit yang diinfeksi dengan P. berghei diberi ekstrak metanol akar pasak bumi dengan dosis 60 mg/kgBB. Antimalaria ditunjukkan dari apusan tipis dan apusan tebal. Sitokin proinflamasi dan antiinflamasi diperiksa dengan bead based multiplexing technique.Hasil. Aktivitas antimalaria ekstrak akar pasak bumi mempunyai daya hambat terhadap parasit sebesar 88,78% (p=0,007) dan rata-rata pertumbuhan parasit yaitu 0,03% (p=0,001). Efek Imunomodulator, dinilai terhadap rata-rata MFI TNF-α, IFN-γ dan IL-10 kelompok yang diterapi ekstrak akar pasak bumi dibandingkan kelompok kontrol secara berturut-turut ± 14,5 : ± 6,2; ±9,2 : ±25,38; ±29,6 : ±14,75.Terdapat korelasi positif penghambatan pertumbuhan parasit dengan nilai TNF-α (r = 0,612, p = 0,06), Korelasi negatif Penghambatan pertumbuhan parasit dengan nilai IFN-γ (r = -0,092, p = 0,814), Korelasi positif penghambatan pertumbuhan parasit dengan nilai IL-10 (r = 0,276, p = 441). Terdapat korelasi negatif antara nilai TNF-α dengan IFN-γ (r = - 0,699, p = 0,036), korelasi positif antara nilai TNF-α dengan IL=10 (r = 0,350, p = 0,355) Kesimpulan ekstrak akar pasak bumi mempunyai efektivitas sebagai antimalaria, dengan mempengaruhi peningkatan sitokin TNF-α dan IL-10, tetapi tidak pada IFN-γ

---

Background. Malaria is still a health issues. Malaria is caused by parasites of the genus Plasmodium. An immune response actually has contribution against infection malaria, among others proinflamation and antiinflamation cytokine play an important role. Extract of pasak bumi root is a drug traditional as antimalarial. Pasak bumi root is also immunomodulator. The aim of this research is to analyze of an extract of methanol of Pasak bumi root as antimalarial against the level of a proinflamation and antiinflamation cytokines on mice is infected by P. berghei Methods. 5 mouse are infected by P. berghei, are given extract of pasak bumi root with dose 60 mg/kg BB. Antimalaria is shown by apusan tipis and apusan tebal. Proinflamasi and antiinflamasi is examined by bead based multiplexing technique.Result. Antimalarials activity has its obstruent against parasitic about 88,78% (p = 0,007) and The average growth of the parasitic 0,03% (p = 0,001). Effect of immunomodulator, mean of MFI TNF-α, IFN-γ and IL-10 on a group that is in therapy is compared on an group that are not in therapy respectively ± 14,5 : ± 6,2; ±9,2 : ±25,38; ±29,6 : ±14,75. There is a positive correlation between Growth inhibitor of parasitic and TNF-α. (r = 0,612, p = 0,06). There is a negative correlation between growth inhibitor of parasitic and IFN-γ (r = -0,092, p = 0,814) and there is a positive correlation between growth inhibitor of parasitic and IL-10 (r = 0,276, p = 0,441). There is a negative correlation between score of TNF-α and IFN-γ (r = -0,699, p = 0,036) between TNF-α. and IL-10 (r = 0,350, p = 0,355). Conclusions. An extract of Pasak bumi root a have an antimalarial the effectiveness and influence to TNF-α and IL-10 but not on IFN- γ"

"[ABSTRAKInfeksi parasit usus merupakan infeksi yang banyak terjadi di daerah tropis dan subtropis terutama daerah dengan fasilitas sanitasi, air dan kebersihan yang tidak adekuat. Terbatasnya sumber air konsumsi diperkirakan menjadi penyebab tingginya infeksi. Anak-anak merupakan populasi yang rentan terhadap infeksi parasit usus. Penelitian bertujuan mengetahui prevalensi infeksi parasit usus pada anak-anak dan hubungannya dengan sumber air konsumsi. Penelitian dilakukan di TPA Bantar Gebang Bekasi, Jawa Barat tahun 2012. Metode penelitian yaitu Cross-Sectional. Pengambilan data melalui kuesioner dan pemeriksaan feses yang melibatkan 139 anak usia 0-15 tahun. Pemeriksaan feses menggunakan metode Kato Katz dan teknik identifikasi protozoa usus dengan larutan lugol atau eosin.Data yang diperoleh diproses dengan SPSS versi 16.0 dan dianalisis dengan uji Chi-square. Hasil penelitian menunjukan prevalensi infeksi parasit usus 72,7%. Infeksi disebabkan oleh Blastocystis hominis 53,5%, Giardia lamblia 30,9%, Trichuris trichura 20,9%, Ascaris lumbricoides 4,3% dan Entamoeba histolytica 2%. Uji Chi-square tidak menunjukan perbedaan bermakna antara prevalensi infeksi parasit usus yang dihubungkan dengan sumber air konsumsi (p>0,05). Disimpulkan bahwa prevalensi infeksi parasit usus pada anak-anak di TPA Bantar Gebang tinggi dengan Blastocystis hominis merupakan parasit yang paling banyak menginfeksi. Selain itu, sumber air konsumsi tidak berhubungan dengan infeksi parasit usus.

---

ABSTRACTIntestinal parasitic infection is the most infection in tropic and subtropics regions where sanitation facilities, water and hygiene are inadequate. Limited of consumption water resource is estimated to be the cause of high infection. Children is a susceptible population of intestinal parasitic infection. The aim of this study was determine the prevalence of intestinal parasitic infection among children and its relationship with consumption water resource. This study was conducted in TPA Bantar Gebang Bekasi, West Java on 2012. The method of study was cross-sectional. Data was collected by questioner and stool examination on 139 children within 0-15 years old. Stool examination was determined using Kato Kats method and intestinal protozoa identification technique using lugol or eosin solution. Data was processed by SPSS version 16.0 and analyzed by Chi-square test. The result showed prevalence of intestinal parasitic infection was 72,7%. The infection caused by Blastocystis hominis (53,5%), Giardia lamblia (30,9%), Trichuris trichura (20,9%), Ascaris lumbricoides (4,3%) and Entamoeba histolytica (2%). Chi-square test did not showed significant difference of prevalence of intestinal parasitic infection and its relationship with consumption water resource (p>0,05). In conclusion, prevalence of intestinal parasitic infection among children in TPA Bantar Gebang was high that mostly caused by Blastocystis hominis. Moreover, consumption water resource had not relationship with prevalence of intestinal parasitic infection.;Intestinal parasitic infection is the most infection in tropic and subtropics regions where sanitation facilities, water and hygiene are inadequate. Limited of consumption water resource is estimated to be the cause of high infection.Children is a susceptible population of intestinal parasitic infection. The aim of this study was determine the prevalence of intestinal parasitic infection among children and its relationship with consumption water resource. This study was conducted in TPA Bantar Gebang Bekasi, West Java on 2012. The method of study was cross-sectional. Data was collected by questioner and stool examination on 139 children within 0-15 years old. Stool examination was determined using Kato Kats method and intestinal protozoa identification technique using lugol or eosin solution. Data was processed by SPSS version 16.0 and analyzed by Chi-square test. The result showed prevalence of intestinal parasitic infection was 72,7%. The infection caused by Blastocystis hominis(53,5%), Giardia lamblia (30,9%), Trichuris trichura (20,9%), Ascarislumbricoides (4,3%) and Entamoeba histolytica (2%). Chi-square test did not showed significant difference of prevalence of intestinal parasitic infection and its relationship with consumption water resource (p>0,05). In conclusion, prevalence of intestinal parasitic infection among children in TPA Bantar Gebang was high that mostly caused by Blastocystis hominis. Moreover, consumption water resource had not relationship with prevalence of intestinal parasitic infection.;Intestinal parasitic infection is the most infection in tropic and subtropics regions where sanitation facilities, water and hygiene are inadequate. Limited of consumption water resource is estimated to be the cause of high infection.Children is a susceptible population of intestinal parasitic infection. The aim of this study was determine the prevalence of intestinal parasitic infection among children and its relationship with consumption water resource. This study was conducted in TPA Bantar Gebang Bekasi, West Java on 2012. The method of study was cross-sectional. Data was collected by questioner and stool examination on 139 children within 0-15 years old. Stool examination was determined using Kato Kats method and intestinal protozoa identification technique using lugol or eosin solution. Data was processed by SPSS version 16.0 and analyzed by Chi-square test. The result showed prevalence of intestinal parasitic infection was 72,7%. The infection caused by Blastocystis hominis(53,5%), Giardia lamblia (30,9%), Trichuris trichura (20,9%), Ascarislumbricoides (4,3%) and Entamoeba histolytica (2%). Chi-square test did not showed significant difference of prevalence of intestinal parasitic infection and its relationship with consumption water resource (p>0,05). In conclusion, prevalence of intestinal parasitic infection among children in TPA Bantar Gebang was high that mostly caused by Blastocystis hominis. Moreover, consumption water resource had not relationship with prevalence of intestinal parasitic infection., Intestinal parasitic infection is the most infection in tropic and subtropics regions where sanitation facilities, water and hygiene are inadequate. Limited of consumption water resource is estimated to be the cause of high infection.Children is a susceptible population of intestinal parasitic infection. The aim of this study was determine the prevalence of intestinal parasitic infection among children and its relationship with consumption water resource. This study was conducted in TPA Bantar Gebang Bekasi, West Java on 2012. The method of study was cross-sectional. Data was collected by questioner and stool examination on 139 children within 0-15 years old. Stool examination was determined using Kato Kats method and intestinal protozoa identification technique using lugol or eosin solution. Data was processed by SPSS version 16.0 and analyzed by Chi-square test. The result showed prevalence of intestinal parasitic infection was 72,7%. The infection caused by Blastocystis hominis(53,5%), Giardia lamblia (30,9%), Trichuris trichura (20,9%), Ascarislumbricoides (4,3%) and Entamoeba histolytica (2%). Chi-square test did not showed significant difference of prevalence of intestinal parasitic infection and its relationship with consumption water resource (p>0,05). In conclusion, prevalence of intestinal parasitic infection among children in TPA Bantar Gebang was high that mostly caused by Blastocystis hominis. Moreover, consumption water resource had not relationship with prevalence of intestinal parasitic infection.]"

"ABSTRAKMalaria merupakan penyakit infeksi dengan prevalensi yang tinggi di Indonesia. Peningkatan resistensi terhadap pengobatan malaria telah ditemukan di beberapa negara untuk mengindikasikan bahwa penelitian dan pengembangan antimalaria baru sangat dibutuhkan. Penelitian ini bertujuan untuk menemukan antimalaria alternatif, dengan memanfaatkan ekstrak tanaman herbal, yaitu Spirulina dan Pasak Bumi. Penelitian ini merupakan penelitian eksperimental yang menguji pemberian Spirulina secara tunggal dan kombinasi dengan ekstrak akar Pasak Bumi terhadap mencit Mus musculus yang terinfeksi Plasmodium berghei. Dosis Spirulina yang digunakan pada penelitian ini adalah 300 mg/kgBB dan 500 mg/kgBB sedangkan dosis ekstrak Pasak Bumi yang digunakan adalah 60 mg/kgBB dan 75 mg/kgBB. Pada semua kelompok perlakuan terjadi peningkatan tingkat parasitemia pada hari ke-4 dengan persentase inhibisi parasitemia yang negatif. Hal ini menunjukkan bahwa Spirulina dosis 300 mg/kgBB dan 500 mg/kgBB dan ekstrak akar pasak bumi dosis 60 mg/kgBB dan 75 mg/kgBB tidak memiliki efek antimalaria, Dengan demikian, dapat disimpulkan bahwa pemberian ekstrak Spirulina tunggal dan kombinasi Spirulina dengan ekstrak Pasak Bumi pada dosis di atas tidak efektif sebagai antimalaria.

---

ABSTRACTMalaria is an infectious disease with high prevalence in Indonesia. Increasing in resistance to malaria therapy has been observed in several countries to indicate that new antimalarial studies and development are needed. This study is aimed to find alternative antimalaria by using herbal plant extracts, namely Spirulina and Pasak Bumi. This study is an experimental study that tested the Spirulina administration singly and in combination with the extract of Pasak Bumi root to the mice Mus musculus infected with Plasmodium berghei. The dosage of Spirulina used in this study was 300 mg kgBW and 500 mg kgBW while the dosage of Pasak Bumi root extract was 60 mg kgBW and 75 mg kgBW. In all treatment groups, there was an increased level of parasitemia on day 4 with negative parasitemia inhibition percentage. It shows that Spirulina dose of 300 mg kgBW and 500 mg kg BW and Pasak Bumi root extract by dose 60 mg kgBB and 75 mg kgBW have no antimalarial effect. Thus, it can be concluded that administration of Spirulina singly and the combination of Spirulina and Pasak Bumi root extract are not effective as antimalaria."

"[Pengobatan malaria semakin lama mengalami resistensi di berbagai daerah. Akar pasak bumi (Eurycoma longifolia) adalah tanaman yang berpotensi sebagai terapi malaria karena memiliki kandungan kuasinoid. Penelitian ini melakukan uji ekstrak akar pasak bumi (E. longifolia) dosis 60 mg/kgBB dan 75 mg/kgBB secara tunggal dan kombinasi masing-masing dengan klorokuin via oral. Jenis penelitian eksperimental in vivo dengan subjek penelitian mencit Swiss yang terinfeksi Plasmodium berghei. Hasil penelitian perbandingan hari ke-4 dan hari ke-0 tingkat parasitemia memiliki nilai signifikan (p<0,05) pada uji One way Anova. Persentase inhibisi pertumbuhan pada kelompok kombinasi mencapai 98,5% dan 98,9% dibandingkan klorokuin sebagai obat standar mencapai 100%. Sedangkan pasak bumi tunggal inhibisi <50%. Dapat disimpulkan pemberian kombinasi lebih baik menurunkan dan menekan parasitemia dibandingkan pemberian ekstrak akar pasak bumi secara tunggal berdasarkan hasil analisis data perbedaan bermakna (p<0,05).;Malaria treatment is going to become resistance in various regions. Eurycoma longifolia jack is a plant that has potential as malaria therapy due to contain quassinoid as antimalarial. This study was to test Eurycoma longifolia jack extract dose 60 mg/kgBB and 75 mg/kgBB in single and combination with chloroquine via oral. Type of studies is experimental in vivo with Swiss mice infected by Plasmodium berghei as subject. Results of comparative study day 4 and day 0 levels of parasitemia has significant value (p<0,05). The percentage of growth inhibition in the combination group reached 98,5% and 98,9% compare with reference standard therapy chloroquine that reached 100%, while the single of Eurycoma longifolia jack <50%. It can be concluded combination group better than single group of Eurycoma longifolia jack to reduce and supress parasitemia based on the post-hoc analysis there were significant differences (p<0,05)., Malaria treatment is going to become resistance in various regions. Eurycoma longifolia jack is a plant that has potential as malaria therapy due to contain quassinoid as antimalarial. This study was to test Eurycoma longifolia jack extract dose 60 mg/kgBB and 75 mg/kgBB in single and combination with chloroquine via oral. Type of studies is experimental in vivo with Swiss mice infected by Plasmodium berghei as subject. Results of comparative study day 4 and day 0 levels of parasitemia has significant value (p<0,05). The percentage of growth inhibition in the combination group reached 98,5% and 98,9% compare with reference standard therapy chloroquine that reached 100%, while the single of Eurycoma longifolia jack <50%. It can be concluded combination group better than single group of Eurycoma longifolia jack to reduce and supress parasitemia based on the post-hoc analysis there were significant differences (p<0,05).]"